EqCap: Quantifying Downside Risk Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics:

EqCap target hurdle rate: 15% IRR (Exhibit 1).
Portfolio valuation: $480M total assets under management (Paragraph 4).
Current cash position: $42M (Paragraph 6).
Projected loss exposure: 22% of capital in the primary industrial segment (Exhibit 3).

Operational Facts:

Headcount: 14 investment professionals (Paragraph 2).
Geography: Primary focus on North American mid-market manufacturing (Paragraph 3).
Process: Standard investment committee approval requires 75% consensus (Paragraph 8).

Stakeholder Positions:

CEO (Mark Sterling): Favors aggressive expansion to maintain market share (Paragraph 12).
CFO (Sarah Jenkins): Advocates for risk-weighted capital allocation to preserve liquidity (Paragraph 14).

Information Gaps:

Lack of detailed sensitivity analysis on commodity price fluctuations beyond 12 months.
Missing data on potential exit multiples for the 2025-2027 window.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How should EqCap balance the aggressive pursuit of market share against the liquidity constraints imposed by current market volatility?

Structural Analysis

Value Chain: The current reliance on mid-market manufacturing exposes the firm to cyclical downturns. Diversification is necessary but capital-intensive.

Strategic Options

Option 1: Defensive Consolidation. Halt new acquisitions and focus on optimizing existing portfolio companies. Trade-off: Preserves $42M liquidity but cedes market share to competitors.
Option 2: Targeted Pivot. Reallocate 30% of capital to high-growth service sectors. Trade-off: High integration risk but reduces exposure to manufacturing cycles.
Option 3: Hybrid Strategy. Maintain existing exposure while hedging commodity risk through derivative instruments. Trade-off: Costs impact margins but maintains growth trajectory.

Preliminary Recommendation

Adopt Option 3. It maintains the growth mandate while mitigating the immediate threat of commodity-driven capital erosion.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Month 1-2: Audit existing commodity exposure across all portfolio assets.
Month 3: Secure hedging instruments with tier-one financial partners.
Month 4: Communicate adjusted capital strategy to limited partners.

Key Constraints

Liquidity Buffer: The $42M cash position is insufficient for long-term hedging; divestiture of one non-core asset is required.
Internal Consensus: The 75% investment committee requirement will slow decision-making; a subcommittee must be formed to expedite hedging approvals.

Risk-Adjusted Implementation

The strategy assumes current market volatility continues. If volatility spikes above 25%, the firm must trigger a pre-defined divestiture clause to protect the 15% IRR hurdle.

4. Executive Review and BLUF (Executive Critic)

BLUF

EqCap must reject the current expansionist path. The firm is over-exposed to cyclical manufacturing. The recommendation to hedge (Option 3) is a tactical stop-gap, not a strategy. The firm should instead divest underperforming assets in the manufacturing segment to unlock $60M in liquidity, then pivot toward software-enabled industrial services. Hedging does not solve the underlying structural issue of asset concentration. Speed is essential; current competitors are already diversifying. If the firm does not act within the next 90 days, the 15% IRR target will be missed by 2026.

Dangerous Assumption

The assumption that hedging can effectively offset the systemic risk of the current portfolio. Hedging protects against price swings but does not improve the fundamental quality of the assets.

Unaddressed Risks

Talent Attrition: The pivot will require new skill sets not present in the current 14-person team.
Exit Window: The plan assumes a stable exit environment, which ignores the potential for a broader credit market tightening.